Same Dose, Different Result: A Sulforaphane Bioavailability Guide

Two products can both place 6 mg beside sulforaphane on a label and still describe very different things. One number may refer to sulforaphane already present in a finished preparation. Another may be an estimated yield from glucoraphanin. A third may describe a daily serve of broccoli sprout material that contains the precursor and the enzyme needed for conversion.

The numbers look equal, but they do not begin at the same point. From the label to the laboratory sample, each dose has to pass through a series of gates. Ingredient identity, active myrosinase, digestive release, individual metabolism and the measurement method can all change what researchers eventually detect.

What Sulforaphane Bioavailability Means

Bioavailability questions become clearer when three amounts are kept separate:

• Stated amount: the number printed on the label or reported for the starting ingredient.
• Generated amount: the sulforaphane formed from glucoraphanin after myrosinase-driven conversion.
• Measured exposure: the sulforaphane or related metabolites found in urine, plasma or another biological sample during a defined collection window.

A health outcome sits one step further downstream. A study can show greater sulforaphane absorption or metabolite recovery without proving that every person will experience a stronger wellbeing effect. Higher bioavailability can improve exposure to the compound, but it does not automatically establish better efficacy or a guaranteed result.

Gate 1: What Entered the System?

The first gate is ingredient identity. Before comparing milligrams, check what the milligrams actually quantify.

Four labels that may look comparable but are not measuring the same starting point

Label type	What enters the product	What the number may represent	Main interpretation limit
Free or stabilised sulforaphane	Sulforaphane is supplied directly in a formulation designed to manage its reactivity or stability.	Actual sulforaphane content at a defined testing point.	Stated content still does not equal the amount absorbed by each person.
Glucoraphanin alone	The relatively stable precursor enters without confirmed active plant myrosinase.	Precursor content or an estimated possible yield.	Conversion may depend more heavily on variable gut microbial activity.
Glucoraphanin plus active myrosinase	Precursor and an active plant enzyme are supplied together.	Glucoraphanin content, enzyme activity, measured sulforaphane or a calculated yield.	The enzyme source, activity, delivery format and testing method still matter.
Whole or lightly processed broccoli sprout material	A food-based matrix can carry glucoraphanin, endogenous myrosinase and other plant components.	Powder weight, precursor level, active enzyme status or a finished-product sulforaphane specification.	The total weight of sprout material is not itself a sulforaphane dose.

This is why glucoraphanin bioavailability, myrosinase bioavailability and sulforaphane bioavailability should not be treated as interchangeable phrases. They describe different parts of the pathway. This is the practical reason why sulforaphane supplements differ even when the front-of-pack numbers look alike.

Gate 2: Did Conversion Have the Right Enzyme?

Glucoraphanin is a precursor. To form sulforaphane, it needs hydrolysis by myrosinase or myrosinase-like activity. When active plant myrosinase is present and able to contact glucoraphanin, conversion can begin earlier and may be less dependent on the individual mix of microbes in the gut.

Processing matters because enzymes are proteins. Heat and other processing conditions can reduce myrosinase activity. That does not mean every dried or milled ingredient has inactive enzyme. It means the finished formulation should be assessed through product-specific processing information and testing rather than assumptions based on the ingredient name alone.

In the PLOS ONE 2015 research, broccoli sprout or seed preparations retaining active endogenous myrosinase produced about three to four times greater sulforaphane bioavailability than glucoraphanin delivered without active plant myrosinase. The study used specific, analytically characterised preparations and urinary metabolite recovery. It does not prove the same multiplier for every broccoli product.

A 2026 randomised, double-blind crossover study tested a defined broccoli seed extract with or without mustard-seed myrosinase, with ascorbic acid included in both arms. Average urinary-metabolite-based bioavailability was 39.8 per cent with the mustard-seed enzyme and 18.6 per cent without it. Those percentages belong to that formulation, dose, participant group and collection method.

A higher conversion percentage in one trial is not a universal conversion rate for every product.

Gut microbes offer another possible conversion route when active plant myrosinase is absent or limited. A 2025 review describes microbial conversion of glucoraphanin into sulforaphane and other related compounds, while also stressing that the contribution of the microbiome is still being clarified. Different people may harbour different organisms and enzyme-like activities, so both the amount and the mix of metabolites can vary.

Gate 3: What Happened During Digestive Transit?

Understanding how sulforaphane is absorbed starts with where conversion and release occur. A capsule, powder and fresh plant food do not release their contents in the same way. Delivery format can influence when glucoraphanin and myrosinase meet, how long they remain together and which digestive conditions they encounter.

• Release from the capsule or food matrix: a standard capsule may open in the stomach, while an enteric format is intended to release later. A fresh food matrix must first be chewed and broken down.
• Exposure to stomach conditions: active plant myrosinase can be sensitive to acidic conditions, but the practical effect depends on the formulation and where conversion has already begun.
• Conversion location: plant-enzyme conversion may begin when plant cells are disrupted or soon after a product releases. Microbial conversion is generally expected later in the digestive tract.
• Timing: earlier conversion can produce a different metabolite curve from slower microbial conversion, even when the starting glucoraphanin amount is similar.
• Research format: food, juice, powder and capsule studies can create different release patterns and are not automatically interchangeable.

The small Nutrients 2019 pilot study examined a glucoraphanin-rich broccoli seed and sprout extract with active myrosinase, gastric acidity and capsule delivery. The findings suggested that gastric conditions and enteric coating affected sulforaphane metabolite recovery in that studied preparation. This is useful formulation evidence, not a general instruction about stomach acid.

Do not start, stop, delay or alter proton-pump inhibitors, antacids or any other medicine to change sulforaphane conversion. Medicine decisions should be made with the prescribing clinician or pharmacist.

It is also worth noticing that studies do not always produce identical delivery-format findings. In the 2015 work, regular and acid-resistant capsules containing a particular freeze-dried sprout preparation produced broadly similar 24-hour urinary recovery. The lesson is not that format never matters or always matters. It is that delivery effects are formulation-specific and need to be tested rather than guessed.

Gate 4: Why the Person Still Matters

Once the same product reaches two people, the pathways can separate again. Sulforaphane absorption is not a fixed machine setting.

• Gut microbiome composition: different microbial communities may vary in their ability to convert glucoraphanin.
• Digestive transit: release and movement through the digestive tract can change the time available for conversion and absorption.
• Baseline diet: habitual food patterns can influence the gut environment and may affect microbial function.
• Metabolite production: sulforaphane can be processed through the mercapturic acid pathway into several related metabolites, and related nitrile products may also be detected.
• Sample type: urine, plasma and stool answer different research questions.
• Sampling window: an 8-hour collection and a 24-hour collection may capture different parts of the response.

The same dose can diverge at five checkpoints

The final number in a paper is therefore not simply the label dose with a percentage attached. It is the result of a defined formulation moving through a defined protocol in a particular group of people.

Evidence Checkpoint: What Human Studies Actually Measured

Study or year	Starting material	Myrosinase present?	What researchers measured	What the result can tell us	What it cannot tell us
PLOS ONE 2015	Glucoraphanin-rich extracts, supplements, freeze-dried sprouts and seed preparations across small human cohorts	Varied by preparation	Mostly 24-hour urinary dithiocarbamate metabolites as a proportion of the administered precursor dose	Active endogenous plant myrosinase materially increased recovery in the studied preparations, with roughly three to four times greater bioavailability than precursor-only material.	It cannot supply one universal conversion rate or prove that an unrelated commercial product performs the same way.
Nutrients 2019	A defined glucoraphanin-rich broccoli seed and sprout extract delivered in a pilot protocol involving gastric acidity and capsule format	Yes	Urinary sulforaphane and metabolites after defined doses and collection periods	Gastric environment and release format can affect a particular active-myrosinase formulation.	It cannot justify changing a medicine or establish one stomach-acid rule for all foods and supplements.
Foods 2023	One serving of fresh broccoli microgreens in 11 healthy participants	Naturally present in the fresh food matrix rather than added as a standardised supplement enzyme	Glucoraphanin and sulforaphane in the food, urinary metabolites, stool metabolites and microbiome composition	A fresh food matrix can produce measurable sulforaphane-related metabolites, with person-to-person variation and several metabolite types.	It cannot rank capsule products or show that a supplement with the same nominal number will behave like fresh microgreens.
Scientific Reports 2026	A standardised broccoli seed extract with ascorbic acid, tested with and without mustard-seed myrosinase in 16 adults	Yes in one arm and no added myrosinase in the comparison arm	Urinary sulforaphane metabolites over early and full 24-hour windows	In that formulation, added mustard-seed myrosinase increased average metabolite-based bioavailability from 18.6 to 39.8 per cent.	It cannot establish universal percentages, predict an individual's result or serve as Kiwi Superfoods product data.

These studies differ in starting material, enzyme source, food matrix, capsule design, participant number and analytical method. Their results are most useful when read as formulation-specific evidence, not as a league table for commercial products.

The Three-Layer Label Reading Rule

1. Ingredient layer

Ask what compound is quantified. Is the number for glucoraphanin, free sulforaphane, total broccoli sprout powder or another preparation? A large milligram number for total powder may represent less direct information about sulforaphane than a smaller, specifically tested compound amount.

2. Conversion layer

Ask what supports glucoraphanin to sulforaphane conversion. Look for active myrosinase, its source, processing designed to retain enzyme activity and formulation-specific testing. The phrase broccoli extract alone does not confirm that active enzyme survived manufacturing.

3. Evidence layer

Ask what kind of number is being presented:

• Product specification: a measured or guaranteed characteristic of the finished product.
• Estimated yield: a calculated amount based on precursor content and an assumed conversion.
• Measured human exposure: sulforaphane or its metabolites detected in people under a defined study protocol.

Only the third layer directly measures human exposure, and even then it reports a group result or a range under study conditions. It does not promise an identical response for a new person.

What the 6 mg Minimum Measures, and What It Cannot Promise

The live Kiwi Superfoods Broccoli Sprout Powder page currently describes the finished product as:

• 100 per cent NZ-grown, lightly milled broccoli sprouts
• air-dried with the intention of preserving active enzyme activity
• guaranteed glucoraphanin and guaranteed active myrosinase
• two 600 mg capsules per daily serve
• a guaranteed minimum 6 mg sulforaphane per daily dose

These are finished-product specifications. They give shoppers more detail than a label that lists only total broccoli powder or only glucoraphanin. They also address both sides of the conversion pathway by identifying the precursor and active myrosinase.

The 6 mg minimum should not be read as a personal absorption result. It does not mean every person absorbs exactly 6 mg, produces the same urinary metabolite level or reaches the same plasma concentration. It does not guarantee a particular health outcome.

It also does not mean Kiwi Superfoods Broccoli Sprout Powder produced the findings in the 2015, 2019, 2023 or 2026 studies. In particular, the 39.8 and 18.6 per cent results from 2026 came from a defined broccoli seed extract and mustard-seed myrosinase formulation. They are not Kiwi Superfoods product data and should not be applied to the 6 mg specification.

The practical reading is simple: the label states what the finished product is designed and tested to provide. Personal sulforaphane uptake remains a separate biological question.

Decision Summary: When the Same Dose Is Not the Same Exposure

1. Identify what the number measures. Separate precursor, active compound, estimated yield and total ingredient weight.
2. Check whether conversion is addressed. Active myrosinase and retained enzyme activity can materially affect the pathway.
3. Look for formulation-specific testing. Ingredient reputation is not a substitute for finished-product information.
4. Separate a product specification from personal absorption. A guaranteed amount is not the same as urinary or plasma exposure in one individual.
5. Do not equate higher bioavailability with a guaranteed health result. Exposure, biological response and personal outcomes are separate layers of evidence.

References

• Fahey and colleagues, PLOS ONE, 2015: Sulforaphane Bioavailability from Glucoraphanin-Rich Broccoli
• Fahey and colleagues, Nutrients, 2019: Bioavailability Following Glucoraphanin-Rich Broccoli Extracts with Active Myrosinase
• Bouranis and colleagues, Foods, 2023: Sulforaphane Bioavailability After Fresh Broccoli Microgreens
• Dmytriv and colleagues, Frontiers in Physiology, 2025: Glucoraphanin Conversion by Gut Microbiota
• Mastaloudis and colleagues, Scientific Reports, 2026: Mustard-Seed Myrosinase and Sulforaphane Bioavailability

FAQs

What does sulforaphane bioavailability mean?

Sulforaphane bioavailability means the proportion of a stated dose that becomes available to the body and is detected through measures such as plasma or urinary metabolites. It is different from the label amount and does not guarantee a health outcome.

Is glucoraphanin the same as bioavailable sulforaphane?

No. Glucoraphanin is the precursor used to form sulforaphane. Its presence shows conversion potential, but actual sulforaphane formation depends on myrosinase or myrosinase-like microbial activity and the conditions of digestion.

Does active myrosinase increase sulforaphane bioavailability?

Human studies suggest that active plant myrosinase can increase sulforaphane formation and measured exposure in the formulations studied. The size of the increase varies by ingredient, enzyme source, delivery format, study design and individual.

Why can the same sulforaphane dose produce different results?

The number may describe a different starting material, and people can differ in digestive release, gut microbiome, transit time, metabolism and sampling timing. These factors can change the amount and pattern of metabolites researchers detect.

How is sulforaphane bioavailability measured in human studies?

Researchers commonly measure sulforaphane and related metabolites in urine or plasma over a defined time. Some studies also assess stool metabolites. Results depend on the sample type, analytical method and collection window.

Does the gut microbiome convert glucoraphanin into sulforaphane?

Yes, some gut microbes can provide myrosinase-like activity and convert glucoraphanin into sulforaphane and related compounds. The efficiency and metabolite mix vary between people, and this remains an evolving research area.

Does stomach acid affect sulforaphane conversion?

Stomach conditions can affect active plant myrosinase and product release, but the practical effect is formulation-specific. Research does not justify changing proton-pump inhibitors, antacids or other medicines to alter sulforaphane conversion.

Does a guaranteed sulforaphane amount equal what my body absorbs?

No. A guaranteed amount is a finished-product specification. Personal absorption and metabolite recovery can differ because of delivery, digestion, microbiome activity, metabolism and the method used to measure exposure.

What should a broccoli sprout supplement label show?

A useful label should identify the starting ingredient, the compound being quantified, whether active myrosinase is present, the serving size and the basis of any sulforaphane figure. Product-specific testing adds more clarity than an estimated conversion alone.

Does higher bioavailability guarantee better health outcomes?

No. Higher bioavailability means greater measured exposure in a defined setting. It does not by itself prove greater efficacy, symptom improvement, disease prevention or the same result for every person.

Next Steps

For a broader view of available formats, browse the broccoli sprouts collection. To understand the starting plant material, read why three-day-old broccoli sprouts matter. For serving-size context without turning this guide into dosage advice, see the sulforaphane supplement dosage guide. For the downstream cellular pathway, visit the sulforaphane and Nrf2 guide.

General information only: This article is educational and does not replace a balanced diet, medical care or medicine advice. Check with a qualified health professional before using a supplement if you are pregnant or lactating, have a thyroid condition, take prescription medicines, have planned surgery, are considering a product for a child, or manage a complex health condition.